COVID19 vaccination
DR. MALCOLM KENDRICK | OCTOBER 25, 2022
I have been somewhat quiet recently. I have started about ten blogs, then got bogged down …. possibly blogged down? Then stopped, and started again, then tore it all up – metaphorically.
The problem is that I have been looking at COVID19 vaccination.
There is much to say, maybe too much. However, one treads a very fine line here. I liken it to walking along a cliffside, in the dark. At any point you can make a small mis-step and plummet to your doom. Or, perhaps it is more like being in the trenches in World War I, knowing that at any point, a sniper could pick you off.
Yes, it is true that WordPress doesn’t seem to care much what anyone writes. Good for them, I say. So, I can write pretty much whatever I want. But the rest of the world watches, waiting for the slightest mistake. At which point you shall be denounced, then silenced, in all other outlets. If this happens, the vast majority of people stop listening to you. ‘Oh him, he’s one of those anti-vaxx nutters. Don’t listen to a word he says.’
Yes, I know there is a large community out there who do not follow the mainstream narrative. Those who know there are – or certainly may be – some significant issues with the COVID19 vaccines. In particular the mRNA vaccines. Speaking to them is easy, gaining their support is easy. They cheer you on.
However, there is no real point in reaching out to them, enjoyable though it may be. It is preaching to the converted. The people that I would really like to get at are those who firmly and absolutely believe that mRNA vaccines are highly effective, absolutely safe, and that everyone should be happy to be vaccinated. Along with their children.
The people who are also very critical of those who do not get vaccinated [I have had three doses, but I shall not be having a fourth, unless things change dramatically].
How do you reach these people? How can you even begin to get them listening to anything you have to say?
To give one example of the problem of starting a discussion. I posted a link in a discussion forum on the Doctors.net website (a website that can only be accessed by UK registered doctors). This link discussed some issues with vaccines. It didn’t seem, to me, to be hyper-critical.
However, I got a message from the moderators informing me that if I attached links to any information critical of vaccines, again, they would remove me from the site. This was my final warning. No discussion.
More recently, the post below was published on the same site. It was in response to a twitter comment which followed an interview with Dr Aseem Malhotra:
‘This is a disgraceful interview with this self-publicising charlatan and hypocrite. He says that “until proven otherwise, it is likely that Covid mRNA vaccines played a significant or primary role in all unexplained heart attacks, strokes, cardiac arrhythmias, & heart failure since 2021”.
That is so grossly irresponsible and untrue It staggers me to think he can be allowed to say this and remain a registered medical practitioner.’
The post I have duplicated here was published by a doctor who works, full-time, for a pharmaceutical company. Something he, surprisingly, failed to mention as a potential conflict of interest. Others piled on in support of him. Many of them agreeing that Aseem Malhotra should be flung off the GMC register forthwith – which would render him unable to work as a doctor.
I suggested that, perhaps it would be better to engage Dr Malhotra in debate, rather than attacking him as a charlatan. At which point I was attacked. In my opinion, if you find yourself being attacked for suggesting that it would be a good idea to have a debate, it is not difficult to work out which way the wind is blowing.
I have discussed vaccination at my local sports club. At which point, almost everyone takes on that silent, arms crossed look, if you mention you have some concerns about vaccines.
They don’t debate the issue, because they can’t, because they don’t know anything other than what they have been told by mainstream media. But it is clear that some of them now see me as a bloody anti-vaxxer. Even if I say nothing more than, ‘I have some concerns.’
Yes, to ask for debate, or to dare express some concerns, is to be labelled an anti-vaxxer.
This is a very high barrier to overcome. I have tried irony. ‘Oh yes, I am absolutely one hundred per cent in favour of COVID19 vaccines. I think everyone should have them four times a year. Pregnant women, children from the moment they are born. No exceptions at all. Yes, these mRNA vaccines have been fully tested. It is clear that they are one hundred per cent safe and one hundred per cent effective. Yup, I cannot see any problems with them at all.’
Response. You are taking the mickey and you are an anti-vaxxer. I claim my prize.
I have also tried saying absolutely nothing at all. I still got accused of being an anti-vaxxer because I did not enthusiasticly agree with criticising someone who was believed to be an anti-vaxxer.
Maybe I should just attend this meeting ‘The New Frontier of RNA Nanotherapeutic. Monday, October 24, 2022 8:30 a.m. – 5 p.m. Hybrid Conference’:
‘The RNA vaccines against COVID-19 mark the beginning of a technological revolution that will transform the way we treat disease and restore health. “The New Frontier of RNA Nanotherapeutics” presented by the George and Angelina Kostas Research Center for Cardiovascular Nanomedicine, will feature a discussion on the events that led to the RNA vaccine breakthrough and preview emerging RNA Nanotherapeutics. Advances in the design of RNA constructs to improve stability and translational efficiency will be presented along with the leading-edge developments in nanomedicine to improve delivery and tissue specificity. The potential of nanotechnology-enabled RNA therapeutics to enhance health is virtually limitless.’
Any doubts I have will evaporate …. maybe.
Anyway. The answer as to … how can I even start a discussion on mRNA vaccines without being shot, falling of the edge of cliff, or being silenced, continues to elude me. Farewell enlightenment. Hello dark ages.
Science, to me, is debate. Science is attacking ideas from all directions. No exceptions. Those ideas which cannot be destroyed may turn out to be correct. But, if an idea is considered sacrosanct, with anyone questioning it condemned as an unbeliever, then we do not have science. We have religion. So yes, in my opinion, vaccines, and vaccination, have become a religious belief. No evidence needed.
Scary. Anyway. If anyone has any good ideas about how a debate can even get started, without descending into anger and accusation … please let me know. It seems beyond me. The end.
Potsdam Climate Institute Scientists Criticized: “Scouring For Most Alarmist Stories”
By Die kalte Sonne | October 22, 2022
Björn Stevens is the director of the Max Planck Institute (MPI) for Meteorology in Hamburg and an expert on clouds. In the Zeit (behind paywall), Stevens expresses criticism of colleagues, primarily at the Potsdam Institute for Climate Impact Research PIK. The Oldenburger Online Zeitung has taken up the interview and quotes indirectly from it.
Among other things, these had warned of the disappearance of all clouds due to global warming. ‘That’s nonsense,’ Stevens said. The scenario is wrong, he said. ‘It’s based on a paper from our institute taken out of context and on a second paper that has numerous flaws.’
The dramatic behavior of the climate in that simulation is based on a gross simplification of clouds that has nothing to do with reality, he said. You can’t get rid of clouds that easily, said Stevens, whose research group simulates clouds in climate models and on whose expertise in cloud issues the world climate report relies heavily. Why his colleagues claimed otherwise, he said, is a question for them to answer. ‘I can only admire the way colleagues there scour the literature for the most alarmist stories.’”
But the blasphemy goes even further.
‘But the tipping points that my colleague Hans Joachim Schellnhuber and others at PIK emphasize are based on their private, much weaker definition. They reinterpret tipping points to include less abrupt or even reversible climate changes. With this new definition, they find tipping points everywhere. Then it’s permanent alarm.’”
Translation by No Tricks Zone
FLORIDA SURGEON GENERAL ON COVID VAX MANDATE
The Highwire with Del Bigtree | October 20, 2022
Florida Surgeon General, Dr. Joseph Ladapo, minces no words regarding his State’s stance on Covid Vaccine Mandates, after a CDC committee voted unanimously to recommend Covid vaccines for kids older than 6 months.
A Tale of Two Pills: Media bias in reporting Ivermectin and ensitrelvir
By Guy Gin | Making (Covid) Waves in Japan | October 21, 2022
Last month, Japanese pharma company Kowa put out a press release of the results of its 1030-person double-blind randomised control trial (RCT) of Ivermectin conducted at 54 institutions in Japan and 2 in Thailand.
Here’s how the results were reported in The Japan Times.

Not effective, you hear! I mean, look at the photo. You don’t get Ivermectin from a pharmacy; you get it from a farmer. Anyway, on to the trial.
A clinical trial was unable to prove the efficacy of the antiparasitic medicine ivermectin against coronavirus variants, according to Japanese drugmaker Kowa Co., which has indicated that it will no longer seek approval for the drug as a COVID-19 treatment.
So this means that not only has IVM not been widely used in Japan (despite what many people outside Japan think) but probably never will be. So what happened? Did the people who took the anti-vaxers’ favourite veterinary medicine all get sick?
In the trial, 1,030 patients with mild COVID-19 were orally administered the drug daily for three days and then compared to others given a placebo.
Ivermectin was found to be safe and few people given the drug developed severe symptoms, Kowa said. But both the group given the drug and the one administered a placebo saw improvements in symptoms, meaning the trial did not show the drug’s efficacy over the placebo as a COVID-19 treatment.
So the reason Kowa was “unable to prove the efficacy” wasn’t because IVM is “not effective”; it was because almost everyone in the placebo group got better quickly too. According to Kowa’s press release, “Both intervention and placebo arms showed milder symptoms around 4 days after the start of administration” and “There were no deaths and hardly any severe cases.”
Although Kowa hasn’t released the full trial details or results, the 0% mortality rate among the 500+ participants in the placebo arm suggests they were mostly at very low risk of severe disease. So the results don’t show IVM was ineffective; they show no medication was necessary for these participants to prevent symptoms worsening or for them to recover quickly.
This a not a new issue in studies on early treatments. Yale epidemiologist Harvey Risch noted the same thing in RCTs showing non-significant effects for another “controversial” drug, hydroxychloroquine.
The RCT studies proclaimed supposedly as definitively showing no benefit of HCQ use in outpatients have all involved almost entirely low-risk subjects with virtually no hospitalization or mortality events and are uninformative and irrelevant for bearing upon these risks according to HCQ use in high-risk outpatients.
When tested on larger numbers of people for mortality benefit, IVM often performs a bit better.

Next, let’s compare how the JT reported Kowa’s IVM trial press release with how Reuters reported Shionogi’s press release for its 1821-person RCT of its anti-Covid drug ensitrelvir.

Japan’s Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial in Asia.
The drug, a protease inhibitor known as ensitrelvir, met its primary endpoint in a trial conducted among predominantly vaccinated patients with mild to moderate cases of COVID-19, the company said in a statement.
A significant reduction in symptoms! So how many people were kept out of the ICU? Well, the Reuters article didn’t clarify what the main result was, so here it is from Shionogi’s press release.
the median time to resolution of the five COVID-19 symptoms [stuffy or runny nose, sore throat, cough, feeling hot or feverish, and low energy or tiredness] was significantly reduced in those treated with the low dose of ensitrelvir (the dose level submitted for approval in Japan) compared to placebo: 167.9 hours versus 192.2 hours, a statistically significant difference of 24 hours (p=0.04).
Yep, ensitrelvir cleared runny noses 1 day quicker than a placebo. So the media reporting of Shionogi’s results wasn’t dishonest, but it wasn’t exactly candid.
Similar to in Kowa’s IVM trial, no deaths were reported among the 900+ placebo recipients in Shionogi’s trial, which again suggests they were very low risk. So these results give us no idea about whether ensitrelvir will prevent the progression to severe disease in high-risk immunocompromised people, which is what actually matters.
Shionogi also reported that no serious adverse events occurred in the intervention arm. But one problem with not trialing a medication on the type of high-risk people who will actually need it is that the trial probably won’t pick up major safety signals that become clear later.

But as El Gato Malo has said, pharma doesn’t make mistakes in trial design; it makes choices.

Safety Reporting of COVID-19 Vaccine Induced Myocarditis Just Seeing the Tip of the Iceberg
By Dr. Peter McCullough & John Leake | Courageous Discourse | October 18, 2022
In 2021 the US CDC and FDA warned America and the world that the mRNA COVID-19 vaccines could result in heart inflammation or myocarditis.[i] This is a medical problem that has occurred in the past not related to vaccines but at a low rate ~4 per million population per year as reported by Arola, et al, from Finland. In general, ~90% of cases occur in men and ~10% in women.[ii]
The principles of management include stopping all forms of exercise since that can be a driver of the development of heart failure and a trigger for sudden death. In cases where there is a progression to heart failure, cardiac biopsy is commonly performed to establish or rule out a diagnosis of giant cell myocarditis which has a markedly worse prognosis than the other forms (parvovirus, etc).
COVID-19 vaccination has been thrust on the world with such vehemence that there has been a hesitancy among physicians and hospitals to spontaneously report cases to the regulatory agencies. The vast majority of physicians took COVID-19 vaccines themselves and may be having trouble coming to personal grips with the threat of heart damage and other risks of vaccination. In 2021 as spontaneous reports came into agencies that predominately young men were developing myocarditis with COVID-19 vaccination, a pattern emerged: 1) highest risk group was males age 18-24 with a skewed distribution and a long tail that extended to men in their seventies, 2) ~90% of required hospitalization, 3) risk was explosive after the second injection, 4) death directly due to myocarditis was confirmed by autopsy.
In the biological licensing agreement letters to Pfizer and Moderna, the US FDA requested prospective cohort studies of myocarditis which call for measurement of blood tests, ECG, and cardiac imaging before injections and at timepoints afterwards to detect the real rate of heart damage and to ascertain how much of the problem could be asymptomatic and potentially present a future risk of sudden death in an unsuspecting patient. Both companies were not forthcoming, so the answer came from Mansanguan et al, from the Bhumibol Adulyadej Hospital, Bangkok, Thailand.[iii] Adolescents age 13-18 were studied in a prospective cohort manner just after the second injection of the Pfizer vaccine and 7/301 (23,256/million) developed myocarditis using a clinical definition based on blood tests, ECG, and cardiac imaging.
Data from multiple sources suggest the condition can be subclinical in about half, meaning neither the patient nor the parents bring it to clinical attention. Patone et al have recently reported on 100 fatal cases of vaccine-induced myocarditis in the UK, and such papers are expected to continue with larger numbers as the medical community begins to fully recognize cause and effect.[iv] Thus spontaneous reporting to agencies represents the tip of a very large iceberg.

If the estimate Mansanguan study is confirmed or anywhere close to ~25,000/million, that means a million young Americans could have sustained heart damage from COVID-19 vaccination and some of them will be at risk for cardiac arrest and future heart failure. These data suggest we should not be surprised by rising rates of sudden death in young persons with sports and during daily life including sleep.
There can be no more urgent need to halt vaccination and commit a substantial research effort into screening, detection, prognosis, and management of COVID-19 vaccine induced myocarditis. The stakes are high—an entire generation is at risk.
COVID Vaccines and Organ Transplants: Are Healthcare Providers Ignoring Safety Signals?

The Defender | October 24, 2022
Since its experimental beginnings in the mid-1950s, organ transplantation has evolved into what the medical community now casually refers to as a “standard-of-care” procedure, albeit one with still substantial failure rates.
For example, though kidneys top the list of transplanted organs, 14% to 21% of kidney transplants fail within five years, and 15% of kidney transplant candidates are awaiting a repeat procedure.
Recent studies identified a new concern related to the failure of transplanted kidneys and other organs: COVID-19 vaccination.
In one study, published in September in Transplant Infectious Disease, researchers cataloged acute organ rejection within a week or two of COVID-19 vaccination in five individuals who had received kidney, liver or heart transplants six to 18 months earlier.
In August, Japanese researchers reported rejection of corneal grafts in COVID-19 vaccine recipients, occurring from one day to six weeks post-vaccination.
The events caught the Japanese authors’ attention because corneal grafts ordinarily have a high success rate due to the cornea’s status as an organ with immune privilege.
Noting literature that documents transplant rejection in association with other vaccines such as influenza, hepatitis B, tetanus and yellow fever, the Japanese authors expressed worry about what “the projected societal shift towards a more frequent vaccination schedule” portends for transplant recipients.
Concerns about the impact of COVID-19 jabs on people with existing transplants are important, but another pressing-yet-unaddressed question lurks in the shadows: What happens if an unvaccinated person receives a transplanted organ from someone who got one or more COVID-19 jabs?
A record year
Although transplantation experienced a brief lull in the early days of the pandemic, by 2021, the U.S. saw a record-setting number of transplants performed — more than 40,000 kidneys, hearts, livers and other organs.
Although supply is never adequate to meet demand, transplant centers were able to achieve their 2021 milestone in part because of a 10% increase over 2020 in the number of “deceased organ donors” (as opposed to living donors), with 45 of 57 organ procurement organizations setting “all-time records for donors recovered in a single year.”
The surge in organ donation from deceased donors represents a decade-long trend, with “the rising number of deaths of young people due to the ongoing opioid epidemic” hypothesized to be a contributing factor prior to 2021. Still, in prior years, the increase averaged only 5%.
Thrilled with the increased availability of organs, transplant organizations have displayed no curiosity about whether fatalities linked to the rollout of experimental COVID-19 vaccines may be eclipsing or even replacing organs sourced from opioid-related deaths — even though there was a 30% increase (over 2020) in organ donation from individuals who died of cardiorespiratory failure, and a 15% increase in organs from deceased 50- to 64-year-olds.
The COVID-19 vaccine rollout has been linked to 2021’s explosive rise in all-cause mortality in the working-age population, including unprecedented heart-related fatalities in younger adult COVID-19 vaccine recipients.
Traffic fatalities are a key pipeline for organ donation, so transplant centers also benefited from the 16-year high in traffic-related deaths in 2021.
Some observers believe these could be linked to COVID-19-vaccine-related loss of consciousness behind the wheel.
Damaged organs?
According to the United Network for Organ Sharing (UNOS), transplant rejection “is when the organ recipient’s immune system recognizes the donor organ as foreign and attempts to eliminate it.”
Rejection begins as an acute phenomenon but may proceed to the gradual loss of organ function defined as chronic rejection.
UNOS says, “Some degree of rejection occurs with every transplant,” which is why immunosuppressive medications, often for life, are a sine qua non following transplantation.
In August, the independent group of doctors and scientists known as Doctors for COVID Ethics outlined disturbing evidence from autopsies of persons deceased after COVID-19 vaccination about what is happening to the organs of mRNA vaccine recipients — organs potentially being offered to transplant recipients.
They noted that mRNA vaccines “travel throughout the body and accumulate in various organs” where they “induce long-lasting expression of the SARS-CoV-2 spike protein” that in turn induces autoimmune-like inflammation — and the vaccine-induced inflammation “can cause grave organ damage, especially in vessels, sometimes with deadly outcome.”
Citing evidence from Pfizer’s animal experiments, they also underscored the particularly rapid accumulation of mRNA vaccine in the liver, and concluded that blood vessels, at the very least, “will be exposed and affected in every organ and in every tissue.”
Other researchers have highlighted “the possibility of subclinical organ dysfunction in vaccinated recipients.”
No transplant for you
Ironically, transplant programs commonly recommend that would-be organ recipients get “up-to-date” on a slew of vaccines — “typically hepatitis A and B, tetanus [diphtheria, pertussis, tetanus], pneumococcus, measles, human papillomavirus, influenza, and others dependent on geography and age.”
Given the manufacturer-documented potential for vaccines to cause organ-damaging adverse events, this advice was already questionable — but then many transplant centers made matters worse by adding stringent requirements for COVID-19 vaccination.
Even though researchers very quickly established that the immunosuppressive drugs taken by transplant recipients guarantee a “significantly blunt[ed]” COVID-19 vaccine response, prominent healthcare systems like Boston’s Brigham and Women’s Hospital and Colorado’s UCHealth did not hesitate to coldly remove the unvaccinated from their transplant waiting lists.
The American Society of Transplant Surgeons’ COVID-19 Strike Force recommends COVID-19 vaccination not just for all transplant candidates but also for recipients, their family members and live donors.
They virtuously claim that decisions to deny transplants to the unvaccinated are based on a desire to “avoid futile transplants and wasting organs that could benefit other candidates.”
A University of Chicago physician who asserted a “legal right to discriminate against candidates who refuse the COVID-19 vaccine” nevertheless squeamishly labeled the discrimination “too severe,” asking, “one must ask how far the [transplant] community will go” and wondering, “will they mandate multiple boosters”?
Big bucks
Although organ transplantation is shrouded in noble lifesaving verbiage, it is also a major profit center for modern medicine.
Global projections for 2021-2028 suggest the combined organ and tissue transplantation market will double in size, going from $7.24 billion to $14.67 billion — and those figures do not take into account a thriving black market for trafficked organs.
Market analysts expect the growth to be fueled both by demand factors — such as the growing incidence of chronic diseases that cause “catastrophic damage to tissue and organs” — and increased supply — including a rise in celebrity-driven organ donation pledges.
Because access to organs remains the key barrier to transplantation, there has also been a push in recent years to allow donation from “suboptimal” or “extended criteria” donors — for example, the elderly, individuals with fatty liver disease, donors with malignancies or viral hepatitis or donations “after cardiac death.”
Will COVID-19-vaccine-contaminated organs become just another category of “suboptimal” donation?
Recent studies of COVID-19 vaccine recipients’ blood suggest that worries about a contaminated blood supply likely also extend to the organ supply and could place transplant recipients’ lives at risk.
Unfortunately, when problems arise, they will probably be chalked up to ordinary transplant rejection, with no one the wiser about the insidious role of newfangled COVID-19 or future mRNA vaccines.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
“We are not QR codes” New Alberta Premier Danielle Smith apologizes for vaccine passports

By Ken Macon | Reclaim The Net | October 24, 2022
During the United Conservative party’s annual general meeting, Alberta’s new Premier Danielle Smith is seeking legal advice on pardoning those that got arrested or fined for violating COVID-19 rules such as not having a vaccine passport.
“We are human beings,” said Smith. “We are not QR codes,” she said, adding that she wanted to “purge” the QR database.
“I believe that Alberta Health Services is the source of a lot of the problems that we’ve had,” she said.
“They signed some kind of partnership with the World Economic Forum right in the middle of the pandemic; we’ve gotta address that. Why in the world do we have anything to do with the World Economic Forum? That’s got to end.”
“The things that come to top of mind for me are people who got arrested as pastors (and) people given fines for not wearing masks,” Smith said. “These are not things that are normal to get fines and get prosecuted for. I’m going to look into the range of outstanding fines and get some legal advice on which ones we are able to cancel and provide amnesty for.”
Smith also doubled down on her promise to amend the Human Rights Act to ban discrimination based on Covid vaccination status. She said the amendment would focus on Covid vaccines because the issue is not medical, it is political.
“Since it was a very specific reaction to a very specific vaccine mandate, we’re going to be very precise when we write the legislation,” she said.
“We have to get back to an attitude of ‘you take a vaccine to protect yourself.’
“[But] we have to get away from this attitude that you demonize those who make a different choice.”
Smith is a vocal opponent of vaccine passports and mandates, especially the Alberta Health Services (AHS) for not allowing people to work if they are not vaccinated against Covid. According to the premier, people not vaccinated against Covid are the most discriminated against she has seen in her life.
Smith vowed to reorganize the AHS governance system and fire the entire board.
“The system, my friends, is broken,” she said. “Most of those managing AHS today are holdovers from the NDP years. They have had their chance to fix this bloated system and they have largely failed on almost all accounts. Failure is no longer an option.”
Smith failed to address the comments she made during a virtual interview with Western Standard about the World Economic Forum (WEF). During the interview, she said she would end the AHS data sharing deal with other health providers, including Mayo Clinic, under a program overseen by the WEF.
U.K. Regulator Mulls Covid Vaccination for Babies Despite High Injury Rate – as Moderna Trial Finds Vaccine Can Cause Diabetes in Infants
BY WILL JONES | THE DAILY SCEPTIC | OCTOBER 21, 2022
The U.K. regulator may decide on whether Covid vaccines should be approved for British babies before Christmas. The Mail has the story.
The Medicines and Healthcare products Regulatory Agency (MHRA), which polices the safety of drugs used in the U.K., told MailOnline it is currently reviewing data on Moderna’s vaccine.
The pharmaceutical firm has submitted evidence in the hope of getting its jab approved for children aged six months and older, as it is in the EU and U.S. Only over-fives can currently get Covid vaccines in the U.K.
Any approval of jabs for babies would cause huge controversy. British authorities have so far held out on approving jabs for infants despite massive pressure, due to concerns that the benefits do not outweigh any potential risks. Children rarely get seriously ill with Covid and the majority are thought to have already been infected.
Experts said today that, even if approved, the jab must not be rolled out “en masse” to healthy infants.
Dr. Laura Squire, the MHRA’s Chief Healthcare Quality and Access Officer, revealed the regulator was processing an application from Moderna. But she added the mRNA jab, which works in a similar way to Pfizer’s, would only be approved if it met strict safety and efficacy standards.
She said: “We have received an application from the company to extend the approval of Moderna to those aged six months to five years. No extension to the vaccine will be approved unless it meets our stringent standards of safety, quality and effectiveness.”
Moderna’s jab application was submitted in mid-September, meaning it has already gone through weeks of analysis. The MHRA declined to detail the timeframe for its expected decision. But it took health chiefs two months to consider the evidence before approving the first Covid jab in December 2020. Moderna’s application is for its existing jab to be rolled out to other groups, rather than for a new drug. Dr. Squire also confirmed rival vaccine maker Pfizer has not yet applied to have its jab approved for use in the youngest children.
Professor David Livermore, a microbiologist at East Anglia University, said giving the jab to the very limited numbers of children with specific conditions might be wise.
He said: “The tiny minorities of children with severe underlying health problems may benefit from vaccination against Covid.”
But he added that a large-scale jab campaign for children should be off the cards. “There should be absolutely no question of mass vaccination of healthy children, for whom the benefits don’t outweigh the risks,” the professor said. “Over 80% of children have now had Covid and have developed natural immunity. This lasts longer than vaccine-induced immunity and is broader in respect of covering variants. Vaccines offer nothing useful to this very large majority.”
Professor Livermore said the risks of vaccine-related harm, while tiny, do not clearly outweigh the very minor benefits for the vast majority of children.
“This is acceptable for elderly vulnerable populations at risk from severe Covid,’ he said. “It’s not acceptable for healthy children, who are at minuscule risk of developing severe Covid.”
He added that he would like Britain to follow Denmark’s lead and stop vaccinating children against Covid unless recommended by a specialist paediatrician.
Worth reading in full.
Moderna has now published the results of its trial in the under-fives. The study population was very small – too small to get meaningful efficacy results and efficacy was “inferred” from “neutralising antibody concentrations”:
The efficacy of mRNA-1273 was inferred on the basis of having met prespecified criteria for immunobridging, the approach used for authorisation and approval in COVID-19 vaccine studies involving adolescents and older children.
In the supplementary appendix (Table S28 and S29) vaccine effectiveness estimates are given which, while the confidence intervals are wide, are all below 51% and one is even negative.
Among children 6-23 months of age, eight serious adverse events occurred in the vaccine group and none in the placebo group. The data in the supplementary appendix consistently show the vaccinated with adverse events of grade 3 (prevents carrying out daily tasks) and grade 4 (hospitalisation) many times higher than either a placebo or lower dose cohort.
Medically attended unsolicited adverse events (Table S26) were two to three times higher in the vaccine cohort than the placebo:
- 1% vaccinated vs 0.3% placebo in 2-5 years
- 1.5% vaccinated vs 0.8% placebo in 6-23 months
- 1.2% vaccinated vs 0.5% placebo in 6 months-5 years
This indicates that 0.7% of the vaccinated or 1 in 143 had an unsolicited side-effect of the vaccine that required medical attention.
Alex Berenson spotted that in the appendix Moderna disclosed a case of new-onset Type 1 diabetes in a one-year-old girl that its investigators found was vaccine-related. This is Moderna admitting that its vaccine can give children diabetes. El Gato Malo points out that this does not appear to have been disclosed ahead of the approval of the vaccine in the U.S.
A German retrospective study found a hospitalisation rate from the (lower dose) Pfizer vaccine in under-fives of around one in 500.
Why are regulators even considering approving these vaccines for small children?

